Quick Answer
Cabaletta Bio, Inc. reported Total Assets of $165.08 million for fiscal year 2025.
Cabaletta Bio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $165.08M | -10.8% |
| 2024 | $185.05M | -27.0% |
| 2023 | $253.65M | +116.9% |
| 2022 | $116.97M | -7.4% |
| 2021 | $126.34M | +10.1% |
| 2020 | $114.72M | -18.9% |
| 2019 | $141.47M | +314.0% |
| 2018 | $34.17M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $189.76M | -7.2% | -15.5% |
| June 30, 2025 | $224.50M | +3.3% | +35.9% |
| March 31, 2025 | $165.14M | -31.3% | -10.8% |
| December 31, 2024 | $185.05M | -27.0% | -9.5% |
| September 30, 2024 | $204.41M | +18.0% | -6.0% |
| June 30, 2024 | $217.42M | +17.8% | -9.6% |
| March 31, 2024 | $240.46M | +132.4% | -5.2% |
| December 31, 2023 | $253.65M | +116.9% | +46.4% |
- Cabaletta Bio, Inc. showed a decrease of -10.8% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Cabaletta Bio, Inc.’s total assets has grown by 383.1% (from $34.17 million to $165.08 million).
- The most recent figure is from Cabaletta Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: